Type 2 diabetes mellitus in children and adolescents

Indian Journal of Pediatrics

Volumn 81, Issue 2, 2014, Pages 165-169

  Tieh, Peter ^a   Dreimane, Daina ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Childhood obesity; Diabetes epidemiology; Diagnosis; Obesity; Pediatrics; Treatment; Type 2 diabetes mellitus in youth and adolescents

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; DIPEPTYL PEPTIDASE 4 INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN SENSITIZING AGENT; METFORMIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA; UNCLASSIFIED DRUG; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ASIA; CHILDHOOD DISEASE; CLINICAL FEATURE; COMORBIDITY; CONFERENCE PAPER; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DRUG SAFETY; EPIDEMIC; GENERAL PRACTITIONER; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE MODIFICATION; MEDICAL SPECIALIST; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; SCREENING TEST; ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; LIFESTYLE;

ADOLESCENT; CHILD; COMORBIDITY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIFE STYLE;

EID: 84898539690     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-013-1193-6     Document Type: Conference Paper

References (14)

1. Writing Group for the SEARCH for Diabetes in Youth Study Group, Dabelea D, Bell RA, D'Agostino RB Jr, Imperatore G, Johansen JM, Linder B, et al. Incidence of diabetes in youth in the United States. JAMA. 2007;297:2716-24.
2. Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care. 2008;1:893-8.
3. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.
4. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Type 2 diabetes in Asian-Indian urban children. Diabetes Care. 2003;24:1022-5. (Pubitemid 36929242)
5. International Diabetes Federation. The Global IDF/ISPAD Guideline for Diabetes in Childhood and Adolescence. 2011.
6. Klingensmith GJ, Pyle L, Arslanian S, Copeland KC, Cuttler L, Kaufman F, et al TODAY Study Group. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype. Diabetes Care. 2010;33:1970-5.
7. Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: The TODAY cohort at baseline. J Clin Endocrinol Metab. 2011;96:159-67.
8. Sapru A, Gitelman SE, Bhatia S, Dubin RF, Newman TB, Flori H. Prevalence and characteristics of type 2 diabetes mellitus in 9-18 year-old children with diabetic ketoacidosis. J Pediatr Endocrinol Metab. 2005;18:865-72. (Pubitemid 41645287)
9. Pinhas-Hamiel O, Zeitler P. Clinical presentation and treatment of type 2 diabetes in children. Pediatr Diabetes. 2007;8:16-27. (Pubitemid 350066644)
10. Loghmani ES. Nutrition therapy for overweight children and adolescents with type 2 diabetes. Curr Diab Rep. 2005;5:385-90. (Pubitemid 41600781)
11. Jones KL, Arslanian S, Peterkova VA, Park JS, Tomlinson MJ. Effect of metformin in pediatric patients with type 2 diabetes: A randomized controlled trial. Diabetes Care. 2002;25:89-94. (Pubitemid 41070789)
12. TODAY Study Group, Zeitler P, Hirst K, Pyle L, Linder B, Copeland K, Arslanian S, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366:2247-56.
13. Levitt Katz LE, Magge SN, Hernandez ML, Murphy KM, McKnight HM, Lipman T. Glycemic control in youth with type 2 diabetes declines as early as two years after diagnosis. J Pediatr. 2011;158:106-11.
14. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403. (Pubitemid 34437694)